Group cuts forecast of revenue growth to 2% as individual states clamp down on vaping
Imperial Brands has warned that a backlash against vaping in the US will push the tobacco company’s profits below expectations for the year.
The FTSE 100 company said the market for “next-generation products” such as its Blu vaping brand had got tougher in the US as government agencies and states had clamped down on vaping. US health officials have identified at least 530 confirmed and probable cases of severe lung-related illnesses and seven deaths linked to vaping.
This post was syndicated from Health | The Guardian. Click here to read the full text on the original website.